PNPLA3 and metabolic dysfunction-associated steatohepatitis: Our first aim in this study was to evaluate and quantify PNPLA3 expression during different stages of liver fibrosis in NASH patients, according to the different PNPLA3 genotypes (WT = C/C or I148M = G/G).